Insiders · Profile

ALEXANDER MARGARET A.

President and CEO at Ovid Therapeutics. Filing since 27 Jan 2025. CIK 0002036798

Company

Date

Role

Action

Amount

Of holding

23 Feb 2026

President and CEO

Sold at will

11,656

$16.90K

15.9%

26 Feb 2025

President and COO

Sold at will

5,279

$2.96K

6.7%

27 Jan 2025

President and COO

Bought

6,810

$4.97K

24.2%

3 decisions on file.